493 related articles for article (PubMed ID: 24464982)
1. Cellular and metabolic alterations in the hippocampus caused by insulin signalling dysfunction and its association with cognitive impairment during aging and Alzheimer's disease: studies in animal models.
Calvo-Ochoa E; Arias C
Diabetes Metab Res Rev; 2015 Jan; 31(1):1-13. PubMed ID: 24464982
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance in the brain: an old-age or new-age problem?
Williamson R; McNeilly A; Sutherland C
Biochem Pharmacol; 2012 Sep; 84(6):737-45. PubMed ID: 22634336
[TBL] [Abstract][Full Text] [Related]
3. (Pre)diabetes, brain aging, and cognition.
S Roriz-Filho J; Sá-Roriz TM; Rosset I; Camozzato AL; Santos AC; Chaves ML; Moriguti JC; Roriz-Cruz M
Biochim Biophys Acta; 2009 May; 1792(5):432-43. PubMed ID: 19135149
[TBL] [Abstract][Full Text] [Related]
4. Cognitive decline in STZ-3V rats is largely due to dysfunctional insulin signalling through the dentate gyrus.
Shingo AS; Kanabayashi T; Murase T; Kito S
Behav Brain Res; 2012 Apr; 229(2):378-83. PubMed ID: 22289199
[TBL] [Abstract][Full Text] [Related]
5. Hippocampal insulin resistance and cognitive dysfunction.
Biessels GJ; Reagan LP
Nat Rev Neurosci; 2015 Nov; 16(11):660-71. PubMed ID: 26462756
[TBL] [Abstract][Full Text] [Related]
6. Lipoic acid improves neuronal insulin signalling and rescues cognitive function regulating VGlut1 expression in high-fat-fed rats: Implications for Alzheimer's disease.
Rodriguez-Perdigon M; Solas M; Moreno-Aliaga MJ; Ramirez MJ
Biochim Biophys Acta; 2016 Apr; 1862(4):511-517. PubMed ID: 26769360
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer disease and cognitive impairment associated with diabetes mellitus type 2: associations and a hypothesis.
Domínguez RO; Pagano MA; Marschoff ER; González SE; Repetto MG; Serra JA
Neurologia; 2014; 29(9):567-72. PubMed ID: 24140159
[TBL] [Abstract][Full Text] [Related]
8. Insulin signalling in Alzheimer's disease and diabetes: from epidemiology to molecular links.
Ribe EM; Lovestone S
J Intern Med; 2016 Nov; 280(5):430-442. PubMed ID: 27739227
[TBL] [Abstract][Full Text] [Related]
9. Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease.
Ferreira ST; Clarke JR; Bomfim TR; De Felice FG
Alzheimers Dement; 2014 Feb; 10(1 Suppl):S76-83. PubMed ID: 24529528
[TBL] [Abstract][Full Text] [Related]
10. Defective Insulin Signalling, Mediated by Inflammation, Connects Obesity to Alzheimer Disease; Relevant Pharmacological Therapies and Preventive Dietary Interventions.
Rodriguez-Casado A; Toledano-Díaz A; Toledano A
Curr Alzheimer Res; 2017; 14(8):894-911. PubMed ID: 28317485
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin G Fc receptor deficiency prevents Alzheimer-like pathology and cognitive impairment in mice.
Fernandez-Vizarra P; Lopez-Franco O; Mallavia B; Higuera-Matas A; Lopez-Parra V; Ortiz-Muñoz G; Ambrosio E; Egido J; Almeida OF; Gomez-Guerrero C
Brain; 2012 Sep; 135(Pt 9):2826-37. PubMed ID: 22961553
[TBL] [Abstract][Full Text] [Related]
12. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
McClean PL; Hölscher C
Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
[TBL] [Abstract][Full Text] [Related]
13. Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease.
Hölscher C
Biochem Soc Trans; 2011 Aug; 39(4):891-7. PubMed ID: 21787319
[TBL] [Abstract][Full Text] [Related]
14. High-sugar diets, type 2 diabetes and Alzheimer's disease.
Moreira PI
Curr Opin Clin Nutr Metab Care; 2013 Jul; 16(4):440-5. PubMed ID: 23657152
[TBL] [Abstract][Full Text] [Related]
15. The impairment of insulin signaling in Alzheimer's disease.
Candeias E; Duarte AI; Carvalho C; Correia SC; Cardoso S; Santos RX; Plácido AI; Perry G; Moreira PI
IUBMB Life; 2012 Dec; 64(12):951-7. PubMed ID: 23129399
[TBL] [Abstract][Full Text] [Related]
16. Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease.
Frisardi V; Solfrizzi V; Seripa D; Capurso C; Santamato A; Sancarlo D; Vendemiale G; Pilotto A; Panza F
Ageing Res Rev; 2010 Oct; 9(4):399-417. PubMed ID: 20444434
[TBL] [Abstract][Full Text] [Related]
17. PI3-kinase/Akt/mTOR signaling: impaired on/off switches in aging, cognitive decline and Alzheimer's disease.
O' Neill C
Exp Gerontol; 2013 Jul; 48(7):647-53. PubMed ID: 23470275
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease.
Grizzanti J; Lee HG; Camins A; Pallas M; Casadesus G
Nutr Res; 2016 Dec; 36(12):1305-1315. PubMed ID: 27923524
[TBL] [Abstract][Full Text] [Related]
19. Obesity and Alzheimer's disease: a link between body weight and cognitive function in old age.
Naderali EK; Ratcliffe SH; Dale MC
Am J Alzheimers Dis Other Demen; 2009 Dec-2010 Jan; 24(6):445-9. PubMed ID: 19801534
[TBL] [Abstract][Full Text] [Related]
20. When aging-onset diabetes is coming across with Alzheimer disease: comparable pathogenesis and therapy.
Tang J; Pei Y; Zhou G
Exp Gerontol; 2013 Aug; 48(8):744-50. PubMed ID: 23648584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
